Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The blood-brain barrier (BBB) continues to represent one of the most significant challenges for successful drug-based treatments of neurological disease. Mechanical modulation of the BBB using focused ultrasound (FUS) and microbubbles (MBs) has shown considerable promise in enhancing the delivery of therapeutics to the brain, but questions remain regarding possible long-term effects of such forced disruption. This review examines the evidence for inflammation associated with ultrasound-induced BBB disruption and potential strategies for managing such inflammatory effects to improve both the efficacy and safety of therapeutic ultrasound in neurological applications.

Original publication

DOI

10.1016/j.tins.2022.03.003

Type

Report

Publication Date

06/2022

Volume

45

Pages

459 - 470

Keywords

blood–brain barrier, cavitation, focused ultrasound, immunomodulation, immunoprivilege, microbubbles, neurological disease, neurovasculature, sterile inflammation, Biological Transport, Blood-Brain Barrier, Brain, Humans, Magnetic Resonance Imaging, Microbubbles, Neuroinflammatory Diseases